| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 95.3 | 91.2 |
| Gross profit | 8.5 | 5.9 |
| Profit before tax | -6.4 | -11.0 |
| Net income | -6.4 | -13.0 |
| EPS (diluted, $ a share) | $-0.45 | $-2.40 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +4.5% |
|---|---|
| Gross margin | 8.9% |
| Operating margin | -3.3% |
Source
Read the filing ↗
10-Q filed with the SEC, OTC: VISK. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Viskase Holdings, Inc.: key numbers
- Share price
- $4.35Close, Nov 13
- Market cap
- $62.3M
- Shares outstanding
- 14.33MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Biological Products, (No Diagnostic Substances)SIC 2836
Today's reference numbers, updated daily. Not a valuation or a recommendation.